Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2007 4
2008 2
2009 3
2010 5
2011 3
2012 5
2013 1
2014 1
2015 2
2016 3
2017 3
2018 3
2019 7
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
The genetics of Kawasaki disease.
Onouchi Y. Onouchi Y. Int J Rheum Dis. 2018 Jan;21(1):26-30. doi: 10.1111/1756-185X.13218. Epub 2017 Nov 19. Int J Rheum Dis. 2018. PMID: 29152908 Review.
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A; KAICA trial Investigators. Hamada H, et al. Among authors: onouchi y. Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7. Lancet. 2019. PMID: 30853151 Clinical Trial.
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A; RAISE study group investigators. Kobayashi T, et al. Lancet. 2012 Apr 28;379(9826):1613-20. doi: 10.1016/S0140-6736(11)61930-2. Epub 2012 Mar 8. Lancet. 2012. PMID: 22405251 Clinical Trial.
Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.
Thiha K, Mashimo Y, Suzuki H, Hamada H, Hata A, Hara T, Tanaka T, Ito K, Onouchi Y; Japan Kawasaki Disease Genome Consortium. Thiha K, et al. Among authors: onouchi y. J Hum Genet. 2019 Jun;64(6):511-519. doi: 10.1038/s10038-019-0588-2. Epub 2019 Mar 11. J Hum Genet. 2019. PMID: 30853710
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
Nakashima Y, Sakai Y, Mizuno Y, Furuno K, Hirono K, Takatsuki S, Suzuki H, Onouchi Y, Kobayashi T, Tanabe K, Hamase K, Miyamoto T, Aoyagi R, Arita M, Yamamura K, Tanaka T, Nishio H, Takada H, Ohga S, Hara T. Nakashima Y, et al. Among authors: onouchi y. Cardiovasc Res. 2019 Nov 29:cvz305. doi: 10.1093/cvr/cvz305. Online ahead of print. Cardiovasc Res. 2019. PMID: 31782770
Correction to: Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.
Thiha K, Mashimo Y, Suzuki H, Hamada H, Hata A, Hara T, Tanaka T, Ito K, Onouchi Y; Japan Kawasaki Disease Genome Consortium. Thiha K, et al. Among authors: onouchi y. J Hum Genet. 2019 Oct;64(10):1049. doi: 10.1038/s10038-019-0645-x. J Hum Genet. 2019. PMID: 31366996
HLA-C variants associated with amino acid substitutions in the peptide binding groove influence susceptibility to Kawasaki disease.
Shimizu C, Kim J, Eleftherohorinou H, Wright VJ, Hoang LT, Tremoulet AH, Franco A, Hibberd ML, Takahashi A, Kubo M, Ito K, Tanaka T, Onouchi Y, Coin LJM, Levin M, Burns JC, Shike H; International Kawasaki Disease Genetic Consortium. Shimizu C, et al. Among authors: onouchi y. Hum Immunol. 2019 Sep;80(9):731-738. doi: 10.1016/j.humimm.2019.04.020. Epub 2019 May 20. Hum Immunol. 2019. PMID: 31122742 Free article.
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial).
Aoyagi R, Hamada H, Sato Y, Suzuki H, Onouchi Y, Ebata R, Nagashima K, Terauchi M, Terai M, Hanaoka H, Hata A; KAICA Trial Investigators. Aoyagi R, et al. Among authors: onouchi y. BMJ Open. 2015 Dec 1;5(12):e009562. doi: 10.1136/bmjopen-2015-009562. BMJ Open. 2015. PMID: 26628527 Free PMC article. Clinical Trial.
Genetics of Kawasaki disease: what we know and don't know.
Onouchi Y. Onouchi Y. Circ J. 2012;76(7):1581-6. doi: 10.1253/circj.cj-12-0568. Epub 2012 Jun 7. Circ J. 2012. PMID: 22789975 Free article. Review.
Identification of LEF1 as a Susceptibility Locus for Kawasaki Disease in Patients Younger than 6 Months of Age.
Kim HJ, Yun SW, Yu JJ, Yoon KL, Lee KY, Kil HR, Kim GB, Han MK, Song MS, Lee HD, Ha KS, Sohn S, Ebata R, Hamada H, Suzuki H, Kamatani Y, Kubo M, Ito K, Onouchi Y, Hong YM, Jang GY, Lee JK. Kim HJ, et al. Among authors: onouchi y. Genomics Inform. 2018 Jun;16(2):36-41. doi: 10.5808/GI.2018.16.2.36. Epub 2018 Jun 30. Genomics Inform. 2018. PMID: 30304924 Free PMC article.
43 results
Jump to page
Feedback